HHC
BLUE

Hutchin Hill Capital’s bluebird bio BLUE Stock Holding History

Hutchin Hill Capital’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-772
Closed -$210K – 610
2013
Q4 		$210K Sell
772
-679
-47% -$190K 0.01% 477
2013
Q3 		$507K Buy
+1,451
New +$539K 0.05% 332

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Hutchin Hill Capital's BLUE Position: Q1 2014 in Review

Hutchin Hill Capital sold out of bluebird bio (BLUE) in Q1 2014, closing a stake of 772 shares — an estimated $210K sold.

Hutchin Hill Capital first reported a position in BLUE in Q3 2013 and held it in 2 quarters. The position peaked at $507K in Q3 2013. 83 funds tracked by Wall St. Rank hold BLUE as of Q1 2014.

  • Hutchin Hill Capital reported no remaining bluebird bio position as of Q1 2014 after selling out during the quarter.
  • Hutchin Hill Capital sold 772 bluebird bio shares in Q1 2014, an estimated $210K.
  • Hutchin Hill Capital first reported a position in bluebird bio in Q3 2013 and held it in 2 quarters.
  • Hutchin Hill Capital's bluebird bio position peaked at $507K in Q3 2013.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q1 2014.

Based on Hutchin Hill Capital's 13F filing for Q1 2014, filed 15 May 2014.